Patents by Inventor Jinseu Park

Jinseu Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8962567
    Abstract: Disclosed is a treatment for ophthalmic diseases, more specifically, a pharmaceutical composition for treating ophthalmic diseases including a fusion protein of FK506 binding protein capable of penetrating into the ocular tissue as an active ingredient.
    Type: Grant
    Filed: April 6, 2011
    Date of Patent: February 24, 2015
    Assignee: Industry Academic Cooperation Foundation, Hallym University
    Inventors: Soo Young Choi, Dae Won Kim, Sung Ho Lee, Jinseu Park, Won Sik Eum
  • Publication number: 20130330368
    Abstract: Disclosed is a treatment for ophthalmic diseases, more specifically, a pharmaceutical composition for treating ophthalmic diseases including a fusion protein of FK506 binding protein capable of penetrating into the ocular tissue as an active ingredient.
    Type: Application
    Filed: April 6, 2011
    Publication date: December 12, 2013
    Applicant: INDUSTRY ACADEIC COOPERATION FOUNDATION, HALLYM UNIVERSITY
    Inventors: Soo Young Choi, Dae Won Kim, Sung Ho Lee, Jinseu Park, Won Sik Eum
  • Patent number: 7902346
    Abstract: Disclosed is a fusion protein containing a FK506 binding protein and a cell-transducing domain. Also, disclosed is a method of making the fusion protein and use of the fusion protein in a pharmaceutical or cosmetic composition. The cell-transducing domain is, for example, a PEP-1.
    Type: Grant
    Filed: June 24, 2008
    Date of Patent: March 8, 2011
    Assignee: Industry Academic Cooperation Foundation, Hallym University
    Inventors: Soo Young Choi, Jinseu Park, Won Sik Eum, Dae-Won Kim, Jin-Hee Choi, Tae-Yoon Kim, Hyung-Joo Kwon
  • Publication number: 20080280830
    Abstract: Disclosed is a fusion protein containing a FK506 binding protein and a cell-transducing domain. Also, disclosed is a method of making the fusion protein and use of the fusion protein in a pharmaceutical or cosmetic composition. The cell-transducing domain is, for example, a PEP-1.
    Type: Application
    Filed: June 24, 2008
    Publication date: November 13, 2008
    Applicant: INDUSTRY ACADEMIC COOPERATION FOUNDATION, HALLYM UNIVERSITY
    Inventors: Soo Young Choi, Jinseu Park, Won Sik Eum, Dae-Won Kim, Jin-Hee Choi, Tae-Yoon Kim, Hyung-Joo Kwon
  • Publication number: 20040058856
    Abstract: This invention relates to delivery of biologically active organic molecules e.g. peptides or proteins into the cytoplasm. In this invention, transducing domain which is covalently attached to organic molecules is oligolysine which comprise 3-12 lysine residues. The oligolysine transducing domain-binding fusion protein is efficiently transducible into cytoplasm, and biologically active.
    Type: Application
    Filed: September 4, 2003
    Publication date: March 25, 2004
    Inventors: Soo-Young Choi, Jinseu Park, Hyeok-Yil Kwon, Jung-Hoon Kang, Tae-Chun Kang, Moo-Ho Won, Kyu-Hyung Han, Kil-Soo Lee